TD Cowen Maintains Hold on P3 Health Partners, Raises Price Target to $14

Benzinga Newsdesk www.benzinga.com Positive 76.9%

Neg 0% Neu 0% Pos 76.9%

TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and raises the price target from $3 to $14.